FORMULASI DAN EVALUASI NANOSTRUCTURED LIPID CARRIER (NLC) SPIRONOLAKTON

Spironolactone is a drug that commonly used to treat hypertension and edema conditions. Additionally, spironolactone also had an effect as antiandrogenic, potentially in the treatment of androgenic alopecia. Target og spironolactone for the treatment of androgenic alopecia is hair follicles. The...

Full description

Saved in:
Bibliographic Details
Main Author: Qadrina, Rahmalia
Format: Final Project
Language:Indonesia
Online Access:https://digilib.itb.ac.id/gdl/view/44554
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Institut Teknologi Bandung
Language: Indonesia
id id-itb.:44554
spelling id-itb.:445542019-10-28T13:48:04ZFORMULASI DAN EVALUASI NANOSTRUCTURED LIPID CARRIER (NLC) SPIRONOLAKTON Qadrina, Rahmalia Indonesia Final Project - INSTITUT TEKNOLOGI BANDUNG https://digilib.itb.ac.id/gdl/view/44554 Spironolactone is a drug that commonly used to treat hypertension and edema conditions. Additionally, spironolactone also had an effect as antiandrogenic, potentially in the treatment of androgenic alopecia. Target og spironolactone for the treatment of androgenic alopecia is hair follicles. The application is used topically. It aims to reduce the dose of medication that can use systemic toxicity when administrated orally. One method used to maximize the delivery of spironolactone to the hair follicle is nano-sized lipid carrier, the NLC (Nanostructured Lipid Carrier). NLC is a typed of colloidal drug delivery systems, generated through the mixing of the solid lipid dan liquid lipid. This study aimed to develop formula of NLC spironolactone in order to fulfill the various parameters. NLC created by using high speed homogenization ultra turax and sonicated using a probe sonicator. The experiment began with the selection of a couple of solid lipid (glyceryl monostearate, cera alba, stearic acid, cetyl alcohol) and liquid lipid (oleic acid, virgin coconut oil and olive oil). The proceed with the selection of a surfactant (Tween 80, Plantacare, Tegocare). Spironolactone NLC evaluation include organoleptic, analysis of particle size, polydispersity index, the efficiency of entrapment and physical stability during storage. NLC Spironolactone was produced in 4,5% glyceryl monostearate, 1,5% oleic acid and 2% Plantacare with 1% active ingredient. Established composition of spironolactone loaded NLC was used for this study, resulting particle size of 137,87 ± 2,46 nm, polidispersity index of 0,29 ± 0,01, potential zeta of -2,13 mV and entrapment efficiency of 91,3%. NLC stability test result for several days showed increasing of particle size but still within the target range. text
institution Institut Teknologi Bandung
building Institut Teknologi Bandung Library
continent Asia
country Indonesia
Indonesia
content_provider Institut Teknologi Bandung
collection Digital ITB
language Indonesia
description Spironolactone is a drug that commonly used to treat hypertension and edema conditions. Additionally, spironolactone also had an effect as antiandrogenic, potentially in the treatment of androgenic alopecia. Target og spironolactone for the treatment of androgenic alopecia is hair follicles. The application is used topically. It aims to reduce the dose of medication that can use systemic toxicity when administrated orally. One method used to maximize the delivery of spironolactone to the hair follicle is nano-sized lipid carrier, the NLC (Nanostructured Lipid Carrier). NLC is a typed of colloidal drug delivery systems, generated through the mixing of the solid lipid dan liquid lipid. This study aimed to develop formula of NLC spironolactone in order to fulfill the various parameters. NLC created by using high speed homogenization ultra turax and sonicated using a probe sonicator. The experiment began with the selection of a couple of solid lipid (glyceryl monostearate, cera alba, stearic acid, cetyl alcohol) and liquid lipid (oleic acid, virgin coconut oil and olive oil). The proceed with the selection of a surfactant (Tween 80, Plantacare, Tegocare). Spironolactone NLC evaluation include organoleptic, analysis of particle size, polydispersity index, the efficiency of entrapment and physical stability during storage. NLC Spironolactone was produced in 4,5% glyceryl monostearate, 1,5% oleic acid and 2% Plantacare with 1% active ingredient. Established composition of spironolactone loaded NLC was used for this study, resulting particle size of 137,87 ± 2,46 nm, polidispersity index of 0,29 ± 0,01, potential zeta of -2,13 mV and entrapment efficiency of 91,3%. NLC stability test result for several days showed increasing of particle size but still within the target range.
format Final Project
author Qadrina, Rahmalia
spellingShingle Qadrina, Rahmalia
FORMULASI DAN EVALUASI NANOSTRUCTURED LIPID CARRIER (NLC) SPIRONOLAKTON
author_facet Qadrina, Rahmalia
author_sort Qadrina, Rahmalia
title FORMULASI DAN EVALUASI NANOSTRUCTURED LIPID CARRIER (NLC) SPIRONOLAKTON
title_short FORMULASI DAN EVALUASI NANOSTRUCTURED LIPID CARRIER (NLC) SPIRONOLAKTON
title_full FORMULASI DAN EVALUASI NANOSTRUCTURED LIPID CARRIER (NLC) SPIRONOLAKTON
title_fullStr FORMULASI DAN EVALUASI NANOSTRUCTURED LIPID CARRIER (NLC) SPIRONOLAKTON
title_full_unstemmed FORMULASI DAN EVALUASI NANOSTRUCTURED LIPID CARRIER (NLC) SPIRONOLAKTON
title_sort formulasi dan evaluasi nanostructured lipid carrier (nlc) spironolakton
url https://digilib.itb.ac.id/gdl/view/44554
_version_ 1822926898604277760